Ureaplasma urealyticum

From WikiMD's WELLNESSPEDIA

(Redirected from U. urealyticum)

Ureaplasma urealyticum is a species of Ureaplasma, a genus of bacteria belonging to the family Mycoplasmataceae. U. urealyticum, while commonly found in the human urogenital tract, has been associated with several diseases, including non-gonococcal urethritis, pelvic inflammatory disease, and adverse pregnancy outcomes.

Taxonomy[edit]

U. urealyticum is a member of the genus Ureaplasma, which is part of the family Mycoplasmataceae. This family also includes the genera Mycoplasma, Acholeplasma, and others. The genus Ureaplasma is distinguished by its ability to metabolize urea.

Microbiology[edit]

U. urealyticum is a small bacterium, lacking a cell wall, which allows it to assume various shapes. This characteristic, known as pleomorphism, is common in the family Mycoplasmataceae. The bacterium is also capable of producing biofilms, which may contribute to its pathogenicity.

Pathogenicity[edit]

While U. urealyticum is often found in the urogenital tract without causing disease, it has been associated with several diseases. These include non-gonococcal urethritis, pelvic inflammatory disease, and adverse pregnancy outcomes such as preterm birth, chorioamnionitis, and neonatal intensive care unit admission.

Treatment[edit]

Treatment of U. urealyticum infections typically involves antibiotics, such as tetracyclines, macrolides, or fluoroquinolones. However, resistance to these antibiotics has been reported.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.